Related Experiment Videos

Infant onset subacute necrotizing encephalomyelopathy (Leigh's disease)

S A Morris1, M G Harbord

  • 1Department of Paediatrics and Child Health, Flinders Medical Centre, Bedford Park, Australia.

Insights

Subacute necrotizing encephalomyelopathy (SNE) in infants presents with seizures and cortical blindness. Measuring blood or cerebrospinal fluid lactate is crucial for diagnosing SNE in infants with unexplained symptoms.

Area of Science:

  • Pediatric Neurology
  • Neurodegenerative Disorders
  • Metabolic Myelopathies

Background:

  • Subacute necrotizing encephalomyelopathy (SNE), also known as Leigh syndrome, is a severe maternally inherited mitochondrial disease.
  • Early diagnosis is critical for management, but clinical presentation can be variable, especially in infants.
  • This study reviews cases of SNE with onset under 12 months to clarify diagnostic challenges.

Observation:

  • Six infants with proven or probable SNE, diagnosed between 1975-1990, were analyzed.
  • Prominent initial symptoms included seizures and cortical blindness, more frequent than previously reported.
  • Respiratory abnormalities and developmental delay were also common clinical features.

Findings:

  • Standard neurophysiological tests (VEP, BAER, EEG) were not diagnostic.
  • Brain imaging (CT scans) showed abnormalities in 3 of 4 cases, including basal ganglia lesions and brain atrophy.
  • Elevated blood or cerebrospinal fluid lactate levels were key indicators, aiding diagnosis in 4 cases.

Implications:

  • Lactate level measurement in blood or CSF should be a routine investigation for infants presenting with unexplained seizures, cortical blindness, or apnea.
  • Increased awareness of atypical presentations of SNE in infancy is necessary for timely diagnosis.
  • Early identification of SNE can guide supportive care and genetic counseling for affected families.

Related Concept Videos